Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): ALT-B4
Therapeutic Area: Oncology Product Name: ALT-B4
Highest Development Status: Discovery Platform Product Type: Large molecule
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $3,881.0 million Upfront Cash: $16.0 million
Deal Type: Licensing Agreement June 24, 2020
Details:
Under the terms of the agreement, Alteogen has granted worldwide rights for TTPC to develop multiple products in combination with ALT-B4.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
